The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

10 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of pyrimidine carboxamides as potent and selective CCK1 receptor agonists.EBI
Merck
Design, synthesis, and biological evaluation of ketoprofen analogs as potent cyclooxygenase-2 inhibitors.EBI
Shahid Beheshti University of Medical Sciences
Chemical and biological investigation of N-hydroxy-valdecoxib: An active metabolite of valdecoxib.EBI
Gedeon Richter
HR1405-01, a Safe intravenous NSAID with superior anti-inflammatory and analgesic activities in preclinical trials.EBI
China Pharmaceutical University
Pyridazine as a privileged structure: An updated review on anticancer activity of pyridazine containing bioactive molecules.EBI
Key Laboratory of Technology of Drug Preparation (Zhengzhou University)
Transformation of Santonin to a Naproxen Analogue with Anti-Inflammatory Activity.EBI
Indian Institute of Integrative Medicine (Csir)
Cyclic enaminone as new chemotype for selective cyclooxygenase-2 inhibitory, anti-inflammatory, and analgesic activities.EBI
National Institute of Pharmaceutical Education and Research (NIPER)
Synthesis and biological activity of structurally diverse phthalazine derivatives: A systematic review.EBI
Y. B. Chavan College of Pharmacy
CULLIN-RING E3 UBIQUITIN LIGASE 4 INHIBITOR COMPOUNDS AND METHODS OF THEIR USEBDB
Icahn School Of Medicine At Mount Sinai
Pyrazole compounds, pharmaceutical compositions thereof and use thereofBDB
Artivila (Shenzhen) Innovation Center